董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Samuel N. Hazen | 男 | Chief Executive Officer and Director | 67 | 2645.66万美元 | 216.41 | 2026-04-23 |
| Andrea B. Smith | 女 | Director | 58 | 37.15万美元 | 0.42 | 2026-04-23 |
| Thomas F. Frist III | 男 | Chairman and Director | 58 | 44.96万美元 | 1.48 | 2026-04-23 |
| John W. Chidsey, III | -- | Director | 63 | 未披露 | 未持股 | 2026-04-23 |
| Michael W. Michelson | 男 | Director | 75 | 43.24万美元 | 1.17 | 2026-04-23 |
| Wayne J. Riley | 男 | Director | 66 | 37.63万美元 | 1.45 | 2026-04-23 |
| Hugh F. Johnston | 男 | Director | 65 | 41.73万美元 | 0.37 | 2026-04-23 |
| William R. Frist | 男 | Director | 57 | 35.26万美元 | 41.59 | 2026-04-23 |
| Nancy Ann DeParle | 女 | Director | 69 | 37.15万美元 | 2.14 | 2026-04-23 |
| John W. Chidsey | 男 | Director | 63 | 23.09万美元 | 0.05 | 2026-04-23 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Samuel N. Hazen | 男 | Chief Executive Officer and Director | 67 | 2645.66万美元 | 216.41 | 2026-04-23 |
| Michael S. Cuffe | 男 | Executive Vice President and Chief Clinical Officer | 60 | 570.42万美元 | 8.47 | 2026-04-23 |
| Christopher F. Wyatt | 男 | Senior Vice President and Controller | 48 | 未披露 | 未持股 | 2026-04-23 |
| Jennifer L. Berres | 女 | Senior Vice President and Chief Human Resources Officer | 55 | 未披露 | 未持股 | 2026-04-23 |
| Michael R. McAlevey | 男 | Executive Vice President — Chief Legal and Administrative Officer | 62 | 571.03万美元 | 3.82 | 2026-04-23 |
| Michael A. Marks | 男 | Executive Vice President and Chief Financial Officer | 56 | 1035.51万美元 | 13.36 | 2026-04-23 |
| Erica L. Rossitto | 女 | Senior Vice President and Chief Nurse Executive | 48 | 未披露 | 未持股 | 2026-04-23 |
| Jon M. Foster | 男 | Executive Vice President and Chief Operating Officer | 64 | 1099.28万美元 | 30.79 | 2026-04-23 |
董事简历
中英对照 | 中文 | 英文- Samuel N. Hazen
-
Samuel N. Hazen在2011年2月被任命为公司运营的总裁。他从2001年7月到2011年2月担任西方集团的总裁，从1995年8月到2001年7月担任公司西方集团的首席财务官。他从1994年2月到1995年7月担任公司北德克萨斯的首席财务官。在此之前，他在不同医院工作，在Humana Inc.和Galen Health Care, Inc.担任区域财务总监职位。
Samuel N. Hazen has served as Chief Executive Officer since January 2019. From November 2016 through December 2018, Mr. Hazen served as the Company's President and Chief Operating Officer. Prior to that, he served as Chief Operating Officer of the Company from January 2015 to November 2016 and as President — Operations of the Company from 2011 to 2015. He also served as President — stern Group from 2001 to 2011 and as Chief Financial Officer — stern Group of the Company from 1995 to 2001. Prior to that time, Mr. Hazen served in vario hospital, regional and division Chief Financial Officer positions with the Company, Humana Inc. and Galen Health Care, Inc. - Samuel N. Hazen在2011年2月被任命为公司运营的总裁。他从2001年7月到2011年2月担任西方集团的总裁，从1995年8月到2001年7月担任公司西方集团的首席财务官。他从1994年2月到1995年7月担任公司北德克萨斯的首席财务官。在此之前，他在不同医院工作，在Humana Inc.和Galen Health Care, Inc.担任区域财务总监职位。
- Samuel N. Hazen has served as Chief Executive Officer since January 2019. From November 2016 through December 2018, Mr. Hazen served as the Company's President and Chief Operating Officer. Prior to that, he served as Chief Operating Officer of the Company from January 2015 to November 2016 and as President — Operations of the Company from 2011 to 2015. He also served as President — stern Group from 2001 to 2011 and as Chief Financial Officer — stern Group of the Company from 1995 to 2001. Prior to that time, Mr. Hazen served in vario hospital, regional and division Chief Financial Officer positions with the Company, Humana Inc. and Galen Health Care, Inc.
- Andrea B. Smith
-
Andrea B. Smith，自2015年7月起担任首席行政官；2010年1月至2015年7月担任人力资源主管。
Andrea B. Smith retired from Bank of America in December 2021 after nearly 34 years with the company. Most recently, she served as chief administrative officer from Augt 2015 through December 2021. Previoly, she led Global Human Resces from January 2010 to Augt 2015. She has served as interim President and Chief Executive Officer of the Charlotte Regional Biness Alliance from May 2024 until April 2025. She chairs the Bank of America Alumni Network and serves on the boards of several nonprofit organizations, including Every Mother Counts and the Charlotte Sports Foundation. Ms. Smith has also served as a director of World Kinect Corporation, a global energy management company, since October 2025. - Andrea B. Smith，自2015年7月起担任首席行政官；2010年1月至2015年7月担任人力资源主管。
- Andrea B. Smith retired from Bank of America in December 2021 after nearly 34 years with the company. Most recently, she served as chief administrative officer from Augt 2015 through December 2021. Previoly, she led Global Human Resces from January 2010 to Augt 2015. She has served as interim President and Chief Executive Officer of the Charlotte Regional Biness Alliance from May 2024 until April 2025. She chairs the Bank of America Alumni Network and serves on the boards of several nonprofit organizations, including Every Mother Counts and the Charlotte Sports Foundation. Ms. Smith has also served as a director of World Kinect Corporation, a global energy management company, since October 2025.
- Thomas F. Frist III
-
Thomas F. Frist III，自2015年12月起担任董事。自2019年4月以来，他曾担任HCA Healthcare，Inc.的董事会主席。自2006年起担任董事。他是first Capital有限责任公司（一家位于田纳西州纳什维尔的投资公司，他于2002年成立，在公共和私人公司进行长期股权投资）的创始人和管理负责人。在此之前，他是FS Partners II，LLC的管理成员，并在Rainwater，Inc.的主要投资部门工作。1992年到1995年。2013年至2017年，他曾担任Science Applications International Corporation的董事。他持有Princeton大学的文学士学位和Harvard Business School的工商管理硕士学位。
Thomas F. Frist III is the founder and managing principal of Frist Capital, LLC, a Nashville based investment firm, and has held such position since 1998. Mr. Frist previoly served as a director of Verisign, Inc. from 2015 2025 and as a director of Science Applications International Corporation from 2013 until 2017. Mr. Frist is the brother of William R. Frist, who also serves as a director of the Company. - Thomas F. Frist III，自2015年12月起担任董事。自2019年4月以来，他曾担任HCA Healthcare，Inc.的董事会主席。自2006年起担任董事。他是first Capital有限责任公司（一家位于田纳西州纳什维尔的投资公司，他于2002年成立，在公共和私人公司进行长期股权投资）的创始人和管理负责人。在此之前，他是FS Partners II，LLC的管理成员，并在Rainwater，Inc.的主要投资部门工作。1992年到1995年。2013年至2017年，他曾担任Science Applications International Corporation的董事。他持有Princeton大学的文学士学位和Harvard Business School的工商管理硕士学位。
- Thomas F. Frist III is the founder and managing principal of Frist Capital, LLC, a Nashville based investment firm, and has held such position since 1998. Mr. Frist previoly served as a director of Verisign, Inc. from 2015 2025 and as a director of Science Applications International Corporation from 2013 until 2017. Mr. Frist is the brother of William R. Frist, who also serves as a director of the Company.
- John W. Chidsey, III
-
John W. Chidsey，III自2026年2月起担任挪威邮轮控股有限公司总裁兼首席执行官。Previoly，于2019年11月至2024年12月担任赛百味行政总裁。He previoly曾担任Burger King控股公司的首席执行官，并在Cendant Corporation担任重要领导职务。在其职业生涯的早期，他还曾在百事可乐公司担任过多个高级财务领导职务。Chidsey先生自2025年2月以来一直担任挪威邮轮控股有限公司的董事会成员，previoly在2013年至2022年期间担任该公司的董事。他还曾于2007年至2024年担任Encompass Health Corporation董事、2019年担任布林克国际国际公司董事、2005年至2010年担任Burger King控股公司董事。
John W. Chidsey, III has served as the President and Chief Executive Officer of Norgian Cruise Line Holdings Ltd. since February 2026. Previoly, he served as the Chief Executive Officer of Subway from November 2019 to December 2024. He previoly served as Chief Executive Officer of Burger King Holdings, Inc. and held significant leadership roles at Cendant Corporation. Earlier in his career, he also held vario senior financial leadership roles at PepsiCo, Inc. Mr. Chidsey has served on the board of Norgian Cruise Line Holdings Ltd. since February 2025 and previoly served as a director of that company from 2013 to 2022. He has also served as a director of Encompass Health Corporation from 2007 to 2024, Brinker International, Inc. in 2019 and Burger King Holdings, Inc. from 2005 to 2010. - John W. Chidsey，III自2026年2月起担任挪威邮轮控股有限公司总裁兼首席执行官。Previoly，于2019年11月至2024年12月担任赛百味行政总裁。He previoly曾担任Burger King控股公司的首席执行官，并在Cendant Corporation担任重要领导职务。在其职业生涯的早期，他还曾在百事可乐公司担任过多个高级财务领导职务。Chidsey先生自2025年2月以来一直担任挪威邮轮控股有限公司的董事会成员，previoly在2013年至2022年期间担任该公司的董事。他还曾于2007年至2024年担任Encompass Health Corporation董事、2019年担任布林克国际国际公司董事、2005年至2010年担任Burger King控股公司董事。
- John W. Chidsey, III has served as the President and Chief Executive Officer of Norgian Cruise Line Holdings Ltd. since February 2026. Previoly, he served as the Chief Executive Officer of Subway from November 2019 to December 2024. He previoly served as Chief Executive Officer of Burger King Holdings, Inc. and held significant leadership roles at Cendant Corporation. Earlier in his career, he also held vario senior financial leadership roles at PepsiCo, Inc. Mr. Chidsey has served on the board of Norgian Cruise Line Holdings Ltd. since February 2025 and previoly served as a director of that company from 2013 to 2022. He has also served as a director of Encompass Health Corporation from 2007 to 2024, Brinker International, Inc. in 2019 and Burger King Holdings, Inc. from 2005 to 2010.
- Michael W. Michelson
-
Michael W. Michelson，KKR管理有限责任公司高级顾问合伙人，私人股本投资管理公司及KKR有限公司普通合伙人，自2018年1月起至2020年1月退休。此前为KKR管理有限责任公司成员，2009年10月至今。在此之前，Michelson先生是有限责任公司的成员，自1996年以来一直担任Kohlberg Kravis Roberts & Co. L.P.的普通合伙人。1981年加入KKR。Michelson先生在KKR投资组合公司的发展中发挥了重要作用。他的职业生涯始于洛杉矶的Latham & Watkins律师事务所，在那里他参与了广泛的公司业务，同时专门从事管理层收购。他获得了哈佛大学的学士学位和哈佛法学院的法学博士学位。
Michael W. Michelson was a Senior Advisory Partner of KKR & Co. L.P. from January 2018 to the end of 2019. From 2009 to 2018, he was a member of KKR Management LLC, a private equity investment manager and the general partner of KKR & Co. L.P. Before that, Mr. Michelson was a member of the limited liability company which served as the general partner of KKR & Co. L.P. from 1996 to 2009. Prior to that, he was a general partner of KKR & Co. L.P. Mr. Michelson previoly served as a director of the Company from 2006 to 2016. He served as a director of Zimmer Biomet Holdings, Inc., a medical device company, from 2015 to 2024 and was previoly a director of Biomet, Inc. from 2007 to 2015. - Michael W. Michelson，KKR管理有限责任公司高级顾问合伙人，私人股本投资管理公司及KKR有限公司普通合伙人，自2018年1月起至2020年1月退休。此前为KKR管理有限责任公司成员，2009年10月至今。在此之前，Michelson先生是有限责任公司的成员，自1996年以来一直担任Kohlberg Kravis Roberts & Co. L.P.的普通合伙人。1981年加入KKR。Michelson先生在KKR投资组合公司的发展中发挥了重要作用。他的职业生涯始于洛杉矶的Latham & Watkins律师事务所，在那里他参与了广泛的公司业务，同时专门从事管理层收购。他获得了哈佛大学的学士学位和哈佛法学院的法学博士学位。
- Michael W. Michelson was a Senior Advisory Partner of KKR & Co. L.P. from January 2018 to the end of 2019. From 2009 to 2018, he was a member of KKR Management LLC, a private equity investment manager and the general partner of KKR & Co. L.P. Before that, Mr. Michelson was a member of the limited liability company which served as the general partner of KKR & Co. L.P. from 1996 to 2009. Prior to that, he was a general partner of KKR & Co. L.P. Mr. Michelson previoly served as a director of the Company from 2006 to 2016. He served as a director of Zimmer Biomet Holdings, Inc., a medical device company, from 2015 to 2024 and was previoly a director of Biomet, Inc. from 2007 to 2015.
- Wayne J. Riley
-
Wayne J. Riley，他一直担任SUNY Downstate Health Sciences University的总裁（2017年4月以来），在那里他也是内科和卫生政策与管理的终身教授。从2013年到2017年，他担任范德比尔特大学欧文管理研究生院医疗保健管理兼职教授和范德比尔特大学医学院临床医学教授。从2007年到2013年，他担任Meharry Medical College的总裁兼首席执行官。从2003年到2006年，Riley博士担任Baylor College of Medicine的副总裁兼卫生事务和政府关系副院长。Riley博士自2021年起担任Compass Pathways， plc和HeartFlow， Inc.的董事。Riley博士从2010年到2015年担任Vertex Pharmaceuticals Incorporated的董事，从2007年到2013年担任Pinnacle Financial Partners， Inc.的董事，从2013年1月到2013年6月担任亚特兰大联邦储备委员会纳什维尔分行的董事。他是美国内科医师学会的名誉主席和美国国家医学院的当选成员。他也是医疗保险支付咨询委员会（MedPAC）委员和纽约医学院董事会主席。
Wayne J. Riley has served as president of SUNY Downstate Health Sciences University since April 2017, where he is also a tenured professor of internal medicine and health policy and management. From 2013 to 2017, he was Adjunct Professor of Healthcare Management, On Graduate School of Management, Vanderbilt University and Clinical Professor of Medicine, Vanderbilt University School of Medicine. From 2007 to 2013, he served as President and CEO of Meharry Medical College. From 2003 through 2006, Dr. Riley served as Vice President and Vice Dean for Health Affairs and Governmental Relations, Baylor College of Medicine. Dr. Riley has also served as a director of Compass Pathways, plc since 2021 and Heartflow, Inc. since 2021. Dr. Riley served as a director of Vertex Pharmaceuticals Incorporated from 2010 to 2015, Pinnacle Financial Partners, Inc. from 2007 to 2013 and the Federal Reserve Board of Atlanta, Nashville Branch from January 2013 to June 2013. He is President Emerit of the American College of Physicians and an elected member of the National Academy of Medicine. Dr. Riley is also a Commissioner of the Medicare Payment Advisory Commission (MedPAC) and Chair of the Board of Trtees of The New York Academy of Medicine. - Wayne J. Riley，他一直担任SUNY Downstate Health Sciences University的总裁（2017年4月以来），在那里他也是内科和卫生政策与管理的终身教授。从2013年到2017年，他担任范德比尔特大学欧文管理研究生院医疗保健管理兼职教授和范德比尔特大学医学院临床医学教授。从2007年到2013年，他担任Meharry Medical College的总裁兼首席执行官。从2003年到2006年，Riley博士担任Baylor College of Medicine的副总裁兼卫生事务和政府关系副院长。Riley博士自2021年起担任Compass Pathways， plc和HeartFlow， Inc.的董事。Riley博士从2010年到2015年担任Vertex Pharmaceuticals Incorporated的董事，从2007年到2013年担任Pinnacle Financial Partners， Inc.的董事，从2013年1月到2013年6月担任亚特兰大联邦储备委员会纳什维尔分行的董事。他是美国内科医师学会的名誉主席和美国国家医学院的当选成员。他也是医疗保险支付咨询委员会（MedPAC）委员和纽约医学院董事会主席。
- Wayne J. Riley has served as president of SUNY Downstate Health Sciences University since April 2017, where he is also a tenured professor of internal medicine and health policy and management. From 2013 to 2017, he was Adjunct Professor of Healthcare Management, On Graduate School of Management, Vanderbilt University and Clinical Professor of Medicine, Vanderbilt University School of Medicine. From 2007 to 2013, he served as President and CEO of Meharry Medical College. From 2003 through 2006, Dr. Riley served as Vice President and Vice Dean for Health Affairs and Governmental Relations, Baylor College of Medicine. Dr. Riley has also served as a director of Compass Pathways, plc since 2021 and Heartflow, Inc. since 2021. Dr. Riley served as a director of Vertex Pharmaceuticals Incorporated from 2010 to 2015, Pinnacle Financial Partners, Inc. from 2007 to 2013 and the Federal Reserve Board of Atlanta, Nashville Branch from January 2013 to June 2013. He is President Emerit of the American College of Physicians and an elected member of the National Academy of Medicine. Dr. Riley is also a Commissioner of the Medicare Payment Advisory Commission (MedPAC) and Chair of the Board of Trtees of The New York Academy of Medicine.
- Hugh F. Johnston
-
Hugh F. Johnston，他于1987年加入百事公司，并担任各种职务，包括百事公司全球运营执行副总裁；百事可乐北美区总裁；百事公司转型高级副总裁；百事饮料和食品公司高级副总裁兼首席财务官；百事公司负责并购的高级副总裁。1999年至2002年，他曾担任Merck & Co.的零售副总裁。Johnston于2010年被任命为百事公司的首席财务官，负责为百事公司提供战略财务领导，包括确保公司的战略为股东创造价值，向投资者传达公司的战略和业绩，实施资本结构，财务流程和控制，以支持公司的增长和投资回报目标。Johnston目前担任Microsoft Corp.的董事会成员和审计委员会主席，以及HCA Healthcare的董事会成员和审计委员会主席。他还是全球领先的经济智库彼得森国际经济研究所（Peterson Institute for International Economics）的主任。他持有Syracuse University的理学学士学位和University of Chicago的工商管理硕士学位。
Hugh F. Johnston has served as Senior Executive Vice President and Chief Financial Officer of The Walt Disney Company since December 2023. Prior to that time, he served as Vice Chairman of PepsiCo, Inc. from 2015 and Executive Vice President and Chief Financial Officer from 2010. Mr. Johnston also currently serves as a member of the board and chair of the audit committee of Microsoft Corporation. Mr. Johnston is active with several corporate, NGO and academic organizations, including the University of Chicago's Booth School CFO Forum Advisory Board, Syrace University's Whitman School of Management Advisory Council, and the Peterson Institute for International Economics. In addition, he is a member of the Federal Reserve Bank of New York Advisory Council. - Hugh F. Johnston，他于1987年加入百事公司，并担任各种职务，包括百事公司全球运营执行副总裁；百事可乐北美区总裁；百事公司转型高级副总裁；百事饮料和食品公司高级副总裁兼首席财务官；百事公司负责并购的高级副总裁。1999年至2002年，他曾担任Merck & Co.的零售副总裁。Johnston于2010年被任命为百事公司的首席财务官，负责为百事公司提供战略财务领导，包括确保公司的战略为股东创造价值，向投资者传达公司的战略和业绩，实施资本结构，财务流程和控制，以支持公司的增长和投资回报目标。Johnston目前担任Microsoft Corp.的董事会成员和审计委员会主席，以及HCA Healthcare的董事会成员和审计委员会主席。他还是全球领先的经济智库彼得森国际经济研究所（Peterson Institute for International Economics）的主任。他持有Syracuse University的理学学士学位和University of Chicago的工商管理硕士学位。
- Hugh F. Johnston has served as Senior Executive Vice President and Chief Financial Officer of The Walt Disney Company since December 2023. Prior to that time, he served as Vice Chairman of PepsiCo, Inc. from 2015 and Executive Vice President and Chief Financial Officer from 2010. Mr. Johnston also currently serves as a member of the board and chair of the audit committee of Microsoft Corporation. Mr. Johnston is active with several corporate, NGO and academic organizations, including the University of Chicago's Booth School CFO Forum Advisory Board, Syrace University's Whitman School of Management Advisory Council, and the Peterson Institute for International Economics. In addition, he is a member of the Federal Reserve Bank of New York Advisory Council.
- William R. Frist
-
William R. Frist是Frist Capital LLC（Frist先生和某些相关人员的私人投资工具）的负责人，自2003年以来担任该职位。他也是Frisco Partners（另一个Frist家庭投资工具）的普通合伙人。他是Thomas F. Frist III（也是公司的董事）的兄弟。
William R. Frist is a principal of Champion & Co. Inc., a Nashville based investment firm, and has held this position since 2023. From 2003 to 2023, Mr. Frist was a principal in Frist Capital, LLC, a Nashville based investment firm. Mr. Frist currently serves on the Board of Directors of The Frist Foundation and as Chair and President of the Board of Trtees of the Frist Art Meum. Mr. Frist is the brother of Thomas F. Frist III, who also serves as a director of the Company. - William R. Frist是Frist Capital LLC（Frist先生和某些相关人员的私人投资工具）的负责人，自2003年以来担任该职位。他也是Frisco Partners（另一个Frist家庭投资工具）的普通合伙人。他是Thomas F. Frist III（也是公司的董事）的兄弟。
- William R. Frist is a principal of Champion & Co. Inc., a Nashville based investment firm, and has held this position since 2023. From 2003 to 2023, Mr. Frist was a principal in Frist Capital, LLC, a Nashville based investment firm. Mr. Frist currently serves on the Board of Directors of The Frist Foundation and as Chair and President of the Board of Trtees of the Frist Art Meum. Mr. Frist is the brother of Thomas F. Frist III, who also serves as a director of the Company.
- Nancy Ann DeParle
-
Nancy Ann DeParle，她是私募股权公司辅音资本合伙公司的联合创始人，并自2020年1月起担任该公司的管理合伙人。2013年至2019年，她曾担任该公司的合伙人。2009年3月至2013年1月，她在白宫任职，最初担任总统顾问和白宫医疗改革办公室主任，后来担任总统助理和政策副参谋长。2001年至2009年，她曾担任JPMorgan Partners及其继任者CCMP Capital的高级顾问和董事总经理。1993年至2000年，她担任白宫管理和预算办公室卫生和人事副主任，后来担任医疗保险和医疗补助服务中心（当时称为医疗保健融资管理局）的管理员。她还担任CVS Health Corporation的董事（2013年9月以来）。
Nancy Ann DeParle is a co founder of Consonance Capital Partners, a private equity firm, and has also served as a managing partner of the firm since January 2020. She previoly served as a partner of the firm from 2013 to 2019. From March 2009 to January 2013, Ms. DeParle served in the White Hoe, first as Counselor to the President and Director of the White Hoe Office of Health Reform, and later as Assistant to the President and Deputy Chief of Staff for Policy. From 2001 to 2009, Ms. DeParle was a senior advisor and managing director of JPMorgan Partners and its successor, CCMP Capital. From 1993 to 2000, Ms. DeParle served as the Associate Director for Health and Personnel for the White Hoe Office of Management and Budget, and later as the Administrator of the Centers for Medicare and Medicaid Services (then known as the Health Care Financing Administration). Ms. DeParle also served as a director of CVS Health Corporation from 2013 to 2025. - Nancy Ann DeParle，她是私募股权公司辅音资本合伙公司的联合创始人，并自2020年1月起担任该公司的管理合伙人。2013年至2019年，她曾担任该公司的合伙人。2009年3月至2013年1月，她在白宫任职，最初担任总统顾问和白宫医疗改革办公室主任，后来担任总统助理和政策副参谋长。2001年至2009年，她曾担任JPMorgan Partners及其继任者CCMP Capital的高级顾问和董事总经理。1993年至2000年，她担任白宫管理和预算办公室卫生和人事副主任，后来担任医疗保险和医疗补助服务中心（当时称为医疗保健融资管理局）的管理员。她还担任CVS Health Corporation的董事（2013年9月以来）。
- Nancy Ann DeParle is a co founder of Consonance Capital Partners, a private equity firm, and has also served as a managing partner of the firm since January 2020. She previoly served as a partner of the firm from 2013 to 2019. From March 2009 to January 2013, Ms. DeParle served in the White Hoe, first as Counselor to the President and Director of the White Hoe Office of Health Reform, and later as Assistant to the President and Deputy Chief of Staff for Policy. From 2001 to 2009, Ms. DeParle was a senior advisor and managing director of JPMorgan Partners and its successor, CCMP Capital. From 1993 to 2000, Ms. DeParle served as the Associate Director for Health and Personnel for the White Hoe Office of Management and Budget, and later as the Administrator of the Centers for Medicare and Medicaid Services (then known as the Health Care Financing Administration). Ms. DeParle also served as a director of CVS Health Corporation from 2013 to 2025.
- John W. Chidsey
-
John W. Chidsey， 2013年4月成为公司董事。他是新成立公司Red Book Connect（协助零售、餐饮和酒店业解决复杂的管理挑战，提高运营效率，通过全面基于云技术平台提高盈利能力）的执行董事长。Chidsey先生早前曾担任Burger King Corporation的董事长和首席执行官。在被任命为首席执行官之前，他担任的是总裁和首席财务官；在那之前，担任美洲地区资产和北美地区资产。在他2004年3月被Burger King Corporation聘用之前，Chidsey先生担任了Cendant两个公司分部的董事长和首席执行官： the Vehicle Services Division， 一个59亿美元的分部，包含了Avis Rent A Car, Budget Rent A Car Systems, PHH和Wright Express；the Financial Services Division， 一个14亿美元的分部，包含了Jackson Hewitt。 他于1996年加入Cendant，担任优选联盟（Preferred Alliances）的高级副总裁。1992年至1995年，Chidsey先生在Pepsi担任多个高管职位，包括Pepsi-Cola Eastern Europe的财务董事和PepsiCo World Trading Co., Inc.的首席财务官。Chidsey先生拥有Emory University的金融学和会计学工商管理硕士学位和法学博士学位，以及Davidson College的学士学位。他是佐治亚州亚特兰大Instawares Holding Company的董事，和阿拉巴马州伯明翰HealthSouth的董事，以及北卡罗来纳州戴维森Davidson College的理事。Chidsey先生是一名注册会计师和Georgia Bar Association的成员。
John W. Chidsey has served as President and Chief Executive Officer since February 2026 and has been a director of the Company since February 2025, having previoly served as a director from April 2013 to January 2022. Mr. Chidsey previoly served as CEO of Subway Restaurants from November 2019 – December 2024. Prior to Subway, Mr. Chidsey held the following roles at Burger King Holdings, Inc.: Chief Executive Officer from April 2006 – October 2010, President and Chief Financial Officer from September 2005 – April 2006, President, North America from June 2004 – September 2005 and Executive Vice President, Chief Administrative and Financial Officer from March 2004 – June 2004. From 1996 – 2003, Mr. Chidsey held key leadership positions at Cendant Corporation, where he served as Chairman and CEO of two major divisions. He led the Vehicle Services Division, overseeing brands such as Avis Rent A Car, Budget Rent A Car Systems, PHH, and Wright Express, as ll as the Financial Services Division, which included Jackson Hewitt. Earlier in his career, Mr. Chidsey held vario senior financial leadership roles at PepsiCo beginning in 1992. Mr. Chidsey has served on the board of HCA Healthcare, Inc. (NYSE: HCA) since July 2025 and previoly served on the boards of Encompass Health Corporation (NYSE: EHC), Burger King Holdings (as Chairman), and Brinker International (NYSE: EAT). Mr. Chidsey holds an MBA in Finance and Accounting and a J.D. from Emory University, as ll as a B.A. from Davidson College. - John W. Chidsey， 2013年4月成为公司董事。他是新成立公司Red Book Connect（协助零售、餐饮和酒店业解决复杂的管理挑战，提高运营效率，通过全面基于云技术平台提高盈利能力）的执行董事长。Chidsey先生早前曾担任Burger King Corporation的董事长和首席执行官。在被任命为首席执行官之前，他担任的是总裁和首席财务官；在那之前，担任美洲地区资产和北美地区资产。在他2004年3月被Burger King Corporation聘用之前，Chidsey先生担任了Cendant两个公司分部的董事长和首席执行官： the Vehicle Services Division， 一个59亿美元的分部，包含了Avis Rent A Car, Budget Rent A Car Systems, PHH和Wright Express；the Financial Services Division， 一个14亿美元的分部，包含了Jackson Hewitt。 他于1996年加入Cendant，担任优选联盟（Preferred Alliances）的高级副总裁。1992年至1995年，Chidsey先生在Pepsi担任多个高管职位，包括Pepsi-Cola Eastern Europe的财务董事和PepsiCo World Trading Co., Inc.的首席财务官。Chidsey先生拥有Emory University的金融学和会计学工商管理硕士学位和法学博士学位，以及Davidson College的学士学位。他是佐治亚州亚特兰大Instawares Holding Company的董事，和阿拉巴马州伯明翰HealthSouth的董事，以及北卡罗来纳州戴维森Davidson College的理事。Chidsey先生是一名注册会计师和Georgia Bar Association的成员。
- John W. Chidsey has served as President and Chief Executive Officer since February 2026 and has been a director of the Company since February 2025, having previoly served as a director from April 2013 to January 2022. Mr. Chidsey previoly served as CEO of Subway Restaurants from November 2019 – December 2024. Prior to Subway, Mr. Chidsey held the following roles at Burger King Holdings, Inc.: Chief Executive Officer from April 2006 – October 2010, President and Chief Financial Officer from September 2005 – April 2006, President, North America from June 2004 – September 2005 and Executive Vice President, Chief Administrative and Financial Officer from March 2004 – June 2004. From 1996 – 2003, Mr. Chidsey held key leadership positions at Cendant Corporation, where he served as Chairman and CEO of two major divisions. He led the Vehicle Services Division, overseeing brands such as Avis Rent A Car, Budget Rent A Car Systems, PHH, and Wright Express, as ll as the Financial Services Division, which included Jackson Hewitt. Earlier in his career, Mr. Chidsey held vario senior financial leadership roles at PepsiCo beginning in 1992. Mr. Chidsey has served on the board of HCA Healthcare, Inc. (NYSE: HCA) since July 2025 and previoly served on the boards of Encompass Health Corporation (NYSE: EHC), Burger King Holdings (as Chairman), and Brinker International (NYSE: EAT). Mr. Chidsey holds an MBA in Finance and Accounting and a J.D. from Emory University, as ll as a B.A. from Davidson College.
高管简历
中英对照 | 中文 | 英文- Samuel N. Hazen
Samuel N. Hazen在2011年2月被任命为公司运营的总裁。他从2001年7月到2011年2月担任西方集团的总裁，从1995年8月到2001年7月担任公司西方集团的首席财务官。他从1994年2月到1995年7月担任公司北德克萨斯的首席财务官。在此之前，他在不同医院工作，在Humana Inc.和Galen Health Care, Inc.担任区域财务总监职位。
Samuel N. Hazen has served as Chief Executive Officer since January 2019. From November 2016 through December 2018, Mr. Hazen served as the Company's President and Chief Operating Officer. Prior to that, he served as Chief Operating Officer of the Company from January 2015 to November 2016 and as President — Operations of the Company from 2011 to 2015. He also served as President — stern Group from 2001 to 2011 and as Chief Financial Officer — stern Group of the Company from 1995 to 2001. Prior to that time, Mr. Hazen served in vario hospital, regional and division Chief Financial Officer positions with the Company, Humana Inc. and Galen Health Care, Inc.- Samuel N. Hazen在2011年2月被任命为公司运营的总裁。他从2001年7月到2011年2月担任西方集团的总裁，从1995年8月到2001年7月担任公司西方集团的首席财务官。他从1994年2月到1995年7月担任公司北德克萨斯的首席财务官。在此之前，他在不同医院工作，在Humana Inc.和Galen Health Care, Inc.担任区域财务总监职位。
- Samuel N. Hazen has served as Chief Executive Officer since January 2019. From November 2016 through December 2018, Mr. Hazen served as the Company's President and Chief Operating Officer. Prior to that, he served as Chief Operating Officer of the Company from January 2015 to November 2016 and as President — Operations of the Company from 2011 to 2015. He also served as President — stern Group from 2001 to 2011 and as Chief Financial Officer — stern Group of the Company from 1995 to 2001. Prior to that time, Mr. Hazen served in vario hospital, regional and division Chief Financial Officer positions with the Company, Humana Inc. and Galen Health Care, Inc.
- Michael S. Cuffe
Michael S. Cuffe，自2022年1月1日起被任命为执行副总裁兼首席临床官。2011年10月至2021年12月，他曾担任内科服务集团总裁。从2011年10月到2015年1月，他还担任公司的副总裁。在此之前，他从2011年3月到2011年10月担任Duke University Health System的门诊服务副总裁和首席医疗官，从2005年6月到2011年3月担任医疗事务副总裁。2008年6月至2011年3月，他还担任杜克大学医学院医学事务副院长，2009年8月至2010年8月担任医学系副主任，2005年3月至2011年10月担任医学副教授。在此之前，他曾担任杜克临床研究所、杜克大学医学中心和杜克大学医学院的各种领导职务。
Michael S. Cuffe,was appointed Executive Vice President and Chief Clinical Officer effective January 1, 2022. He previously served as President — Physician Services Group from October 2011 through December 2021. From October 2011 to January 2015, Dr. Cuffe also served as a Vice President of the Company. Prior to that time, Dr. Cuffe served Duke University Health System as Vice President for Ambulatory Services and Chief Medical Officer from March 2011 to October 2011 and Vice President Medical Affairs from June 2005 to March 2011. He also served Duke University School of Medicine as Vice Dean for Medical Affairs from June 2008 to March 2011, Deputy Chair of the Department of Medicine from August 2009 to August 2010 and Associate Professor of Medicine from March 2005 to October 2011. Prior that time, Dr. Cuffe served in various leadership roles with the Duke Clinical Research Institute, Duke University Medical Center and Duke University School of Medicine.- Michael S. Cuffe，自2022年1月1日起被任命为执行副总裁兼首席临床官。2011年10月至2021年12月，他曾担任内科服务集团总裁。从2011年10月到2015年1月，他还担任公司的副总裁。在此之前，他从2011年3月到2011年10月担任Duke University Health System的门诊服务副总裁和首席医疗官，从2005年6月到2011年3月担任医疗事务副总裁。2008年6月至2011年3月，他还担任杜克大学医学院医学事务副院长，2009年8月至2010年8月担任医学系副主任，2005年3月至2011年10月担任医学副教授。在此之前，他曾担任杜克临床研究所、杜克大学医学中心和杜克大学医学院的各种领导职务。
- Michael S. Cuffe,was appointed Executive Vice President and Chief Clinical Officer effective January 1, 2022. He previously served as President — Physician Services Group from October 2011 through December 2021. From October 2011 to January 2015, Dr. Cuffe also served as a Vice President of the Company. Prior to that time, Dr. Cuffe served Duke University Health System as Vice President for Ambulatory Services and Chief Medical Officer from March 2011 to October 2011 and Vice President Medical Affairs from June 2005 to March 2011. He also served Duke University School of Medicine as Vice Dean for Medical Affairs from June 2008 to March 2011, Deputy Chair of the Department of Medicine from August 2009 to August 2010 and Associate Professor of Medicine from March 2005 to October 2011. Prior that time, Dr. Cuffe served in various leadership roles with the Duke Clinical Research Institute, Duke University Medical Center and Duke University School of Medicine.
- Christopher F. Wyatt
Christopher F. Wyatt，他于2016年4月被任命为高级副总裁兼总会计师。此前，他曾担任公司的副总裁兼首席财务官，负责信息技术（从2013年1月到2016年4月），以及临床服务集团的首席财务官（从2010年10月到2013年1月）。从2000年到2010年，他曾担任安永会计师事务所（Ernst & Young）的多种职务。
Christopher F. Wyatt,was appointed Senior Vice President and Controller in April 2016. Prior to that time, Mr. Wyatt served the Company as Vice President and Chief Financial Officer — IT&S from January 2013 to April 2016 and Chief Financial Officer — Clinical Services Group from October 2010 until January 2013. From 2000 to 2010, Mr. Wyatt served in various capacities with Ernst & Young LLP.- Christopher F. Wyatt，他于2016年4月被任命为高级副总裁兼总会计师。此前，他曾担任公司的副总裁兼首席财务官，负责信息技术（从2013年1月到2016年4月），以及临床服务集团的首席财务官（从2010年10月到2013年1月）。从2000年到2010年，他曾担任安永会计师事务所（Ernst & Young）的多种职务。
- Christopher F. Wyatt,was appointed Senior Vice President and Controller in April 2016. Prior to that time, Mr. Wyatt served the Company as Vice President and Chief Financial Officer — IT&S from January 2013 to April 2016 and Chief Financial Officer — Clinical Services Group from October 2010 until January 2013. From 2000 to 2010, Mr. Wyatt served in various capacities with Ernst & Young LLP.
- Jennifer L. Berres
Jennifer L. Berres被任命为高级副总裁兼首席人力资源官，于2019年11月1日生效。贝瑞斯女士于1993年加入HCA，并担任过各种职务，包括从2013年4月至2019年10月担任人力资源副总裁。
Jennifer L. Berres,was appointed Senior Vice President and Chief Human Resources Officer effective November 1, 2019. Ms. Berres joined HCA in 1993 and served in various capacities, including as Vice President — Human Resources from April 2013 through October 2019.- Jennifer L. Berres被任命为高级副总裁兼首席人力资源官，于2019年11月1日生效。贝瑞斯女士于1993年加入HCA，并担任过各种职务，包括从2013年4月至2019年10月担任人力资源副总裁。
- Jennifer L. Berres,was appointed Senior Vice President and Chief Human Resources Officer effective November 1, 2019. Ms. Berres joined HCA in 1993 and served in various capacities, including as Vice President — Human Resources from April 2013 through October 2019.
- Michael R. McAlevey
Michael R. McAlevey ，于2022年1月被任命为高级副总裁兼首席法律官。在加入HCA之前，McAlevey 曾在通用电气担任高级法律和行政职务，最近一次是从2018年起担任GE Healthcare的副总裁、总法律顾问和业务发展负责人。在此之前，他曾于2011年至2018年担任通用电气航空的总法律顾问和业务发展负责人，并于2003年至2011年担任通用电气的首席企业、证券和财务顾问。在加入通用电气之前，McAlevey 曾于1998年至2002年担任美国证券交易委员会公司财务部副主任。
Michael R. McAlevey,was appointed Executive Vice President – Chief Legal and Administrative Officer of the Company, effective April 1, 2024. Mr. McAlevey previously served as Senior Vice President and Chief Legal Officer from January 2022 through March 2024. Prior to joining HCA, Mr. McAlevey served in senior legal and executive roles at General Electric, most recently as Vice President, General Counsel and Business Development Leader for GE Healthcare since 2018. Prior to that, he served as General Counsel and Business Development Leader for GE Aerospace from 2011 to 2018 and Chief Corporate, Securities and Finance Counsel for GE from 2003 to 2011. Before joining GE, Mr. McAlevey served as Deputy Director of the United States Securities and Exchange Commission's Division of Corporation Finance from 1998 to 2002.- Michael R. McAlevey ，于2022年1月被任命为高级副总裁兼首席法律官。在加入HCA之前，McAlevey 曾在通用电气担任高级法律和行政职务，最近一次是从2018年起担任GE Healthcare的副总裁、总法律顾问和业务发展负责人。在此之前，他曾于2011年至2018年担任通用电气航空的总法律顾问和业务发展负责人，并于2003年至2011年担任通用电气的首席企业、证券和财务顾问。在加入通用电气之前，McAlevey 曾于1998年至2002年担任美国证券交易委员会公司财务部副主任。
- Michael R. McAlevey,was appointed Executive Vice President – Chief Legal and Administrative Officer of the Company, effective April 1, 2024. Mr. McAlevey previously served as Senior Vice President and Chief Legal Officer from January 2022 through March 2024. Prior to joining HCA, Mr. McAlevey served in senior legal and executive roles at General Electric, most recently as Vice President, General Counsel and Business Development Leader for GE Healthcare since 2018. Prior to that, he served as General Counsel and Business Development Leader for GE Aerospace from 2011 to 2018 and Chief Corporate, Securities and Finance Counsel for GE from 2003 to 2011. Before joining GE, Mr. McAlevey served as Deputy Director of the United States Securities and Exchange Commission's Division of Corporation Finance from 1998 to 2002.
- Michael A. Marks
Michael A. Marks，被任命为执行副总裁兼首席财务官，自2024年5月1日起生效。此前，他曾担任财务高级副总裁（从2023年1月到2024年4月）。从2021年3月到2022年12月，他担任财务运营支持副总裁。在此之前，他从2008年12月到2021年2月担任National Group的首席财务官，从2004年7月到2008年11月担任West Florida分部的首席财务官。他于1996年加入Hca Healthcare, Inc.。
Michael A. Marks,was appointed Executive Vice President and Chief Financial Officer, effective May 1, 2024. He previously served as Senior Vice President — Finance from January 2023 through April 2024. Mr. Marks served as Vice President — Financial Operations Support from March 2021 through December 2022. Prior to that time, he served as CFO of the National Group from December 2008 to February 2021 and CFO of the West Florida Division from July 2004 to November 2008. Mr. Marks joined HCA Healthcare in 1996.- Michael A. Marks，被任命为执行副总裁兼首席财务官，自2024年5月1日起生效。此前，他曾担任财务高级副总裁（从2023年1月到2024年4月）。从2021年3月到2022年12月，他担任财务运营支持副总裁。在此之前，他从2008年12月到2021年2月担任National Group的首席财务官，从2004年7月到2008年11月担任West Florida分部的首席财务官。他于1996年加入Hca Healthcare, Inc.。
- Michael A. Marks,was appointed Executive Vice President and Chief Financial Officer, effective May 1, 2024. He previously served as Senior Vice President — Finance from January 2023 through April 2024. Mr. Marks served as Vice President — Financial Operations Support from March 2021 through December 2022. Prior to that time, he served as CFO of the National Group from December 2008 to February 2021 and CFO of the West Florida Division from July 2004 to November 2008. Mr. Marks joined HCA Healthcare in 1996.
- Erica L. Rossitto
Erica L. Rossitto被任命为高级副总裁兼首席护士执行官，自2026年2月1日起生效。She previoly于2023年12月至2026年1月期间担任高级副总裁兼助理首席护士执行官。在此之前，Rossitto女士于2022年4月至2023年11月担任副总裁兼集团首席护士执行官— American Group & Atlantic Group，并于2020年9月至2022年3月担任副总裁兼集团首席护士执行官— American Group，Clinical Operations Group。Rossitto女士于2000年加入HCA，担任HCA HealthONE Sdish的护士。
Erica L. Rossitto was appointed Senior Vice President and Chief Nurse Executive, effective February 1, 2026. She previoly served as Senior Vice President and Assistant Chief Nurse Executive from December 2023 through January 2026. Prior to that time, Ms. Rossitto served as Vice President and Group Chief Nurse Executive — American Group & Atlantic Group from April 2022 to November 2023 and Vice President and Group Chief Nurse Executive — American Group, Clinical Operations Group from September 2020 to March 2022. Ms. Rossitto joined HCA in 2000 as a nurse at HCA HealthONE Sdish.- Erica L. Rossitto被任命为高级副总裁兼首席护士执行官，自2026年2月1日起生效。She previoly于2023年12月至2026年1月期间担任高级副总裁兼助理首席护士执行官。在此之前，Rossitto女士于2022年4月至2023年11月担任副总裁兼集团首席护士执行官— American Group & Atlantic Group，并于2020年9月至2022年3月担任副总裁兼集团首席护士执行官— American Group，Clinical Operations Group。Rossitto女士于2000年加入HCA，担任HCA HealthONE Sdish的护士。
- Erica L. Rossitto was appointed Senior Vice President and Chief Nurse Executive, effective February 1, 2026. She previoly served as Senior Vice President and Assistant Chief Nurse Executive from December 2023 through January 2026. Prior to that time, Ms. Rossitto served as Vice President and Group Chief Nurse Executive — American Group & Atlantic Group from April 2022 to November 2023 and Vice President and Group Chief Nurse Executive — American Group, Clinical Operations Group from September 2020 to March 2022. Ms. Rossitto joined HCA in 2000 as a nurse at HCA HealthONE Sdish.
- Jon M. Foster
Jon M. Foster于2013年1月被任命为美国集团的总裁。在此之前，他从2011年2月到2013年1月担任西南集团的总裁，从2006年1月至2011年2月担任中央和西德克萨斯部门的部门总裁。他于2001年3月加入HCA，担任位于德克萨斯州，奥斯汀的St. David's HealthCare的总裁兼首席执行官，担任该职位直到2011年2月。在加入该公司之前，他曾在田纳西州，诺克斯维尔的Baptist Health System和在德克萨斯州，休斯顿的The Methodist Hospital System担任各种行政能力。
Jon M. Foster,was appointed Executive Vice President and Chief Operating Officer effective January 1, 2023. Prior to that time, he served as President — American Group from January 2013 to December 2022, President — Southwest Group from February 2011 to January 2013 and Division President for the Central and West Texas Division from January 2006 to February 2011. Mr. Foster joined HCA in March 2001 as President and CEO of St. David's HealthCare in Austin, Texas and served in that position until February 2011. Prior to joining the Company, Mr. Foster served in various executive capacities within the Baptist Health System in Knoxville, Tennessee and The Methodist Hospital System in Houston, Texas.- Jon M. Foster于2013年1月被任命为美国集团的总裁。在此之前，他从2011年2月到2013年1月担任西南集团的总裁，从2006年1月至2011年2月担任中央和西德克萨斯部门的部门总裁。他于2001年3月加入HCA，担任位于德克萨斯州，奥斯汀的St. David's HealthCare的总裁兼首席执行官，担任该职位直到2011年2月。在加入该公司之前，他曾在田纳西州，诺克斯维尔的Baptist Health System和在德克萨斯州，休斯顿的The Methodist Hospital System担任各种行政能力。
- Jon M. Foster,was appointed Executive Vice President and Chief Operating Officer effective January 1, 2023. Prior to that time, he served as President — American Group from January 2013 to December 2022, President — Southwest Group from February 2011 to January 2013 and Division President for the Central and West Texas Division from January 2006 to February 2011. Mr. Foster joined HCA in March 2001 as President and CEO of St. David's HealthCare in Austin, Texas and served in that position until February 2011. Prior to joining the Company, Mr. Foster served in various executive capacities within the Baptist Health System in Knoxville, Tennessee and The Methodist Hospital System in Houston, Texas.